Janet R. NicholsonPhD
Janet Nicholson is Director / Group Leader of CNS Diseases Research at Boehringer Ingelheim, Germany. She received her PhD in Pharmacology from the University of Cambridge in collaboration with Parke-Davis Neuroscience Research Centre. Dr Nicholson conducted a post-doctoral research fellowship at the Mental Health Research Institute, Michigan, USA before returning to Europe to take up a position at the University of Basel, Switzerland where she worked in collaboration with Santhera Pharmaceuticals. Dr Nicholson spent several years at Pfizer, Sandwich, UK, before joining BI in 2011. In her current position, Dr Nicholson leads a multidisciplinary team working in the field of neuropsychiatry.